🇺🇸 FDA
Patent

US 11337988

Use of ouabain antagonists to inhibit viral infection

granted A61KA61K31/58A61K9/0043

Quick answer

US patent 11337988 (Use of ouabain antagonists to inhibit viral infection) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/58, A61K9/0043, A61K9/0078, A61P